NCT03642678

Brief Summary

This study is the secondary phase of Taiwan Prediction Model Project Plan (TPMPP). The investigators try to design a prospective randomized control trial with nutrition intervention to validate 3 prediction models the investigators developed in the first phase. Proper validation of these models is mandatory before they can be applied and implemented into daily clinical practice. At present, around 20 centers with estimated around 550-650 high-risk patients will be enrolled with 1:1 ratio in study and control groups. Following up of parameters about primary and secondary outcomes will be done in both groups. But a pre-designed intervention protocol, which is according to 3 elucidated screening methods, will be applied only to the study group. The total study period will be one year.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
422

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 18, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 22, 2018

Completed
1.8 years until next milestone

Study Start

First participant enrolled

June 1, 2020

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2021

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 26, 2022

Completed
Last Updated

August 9, 2022

Status Verified

August 1, 2022

Enrollment Period

12 months

First QC Date

August 18, 2018

Last Update Submit

August 8, 2022

Conditions

Keywords

Prediction ModelMalnutritionHemodialysis

Outcome Measures

Primary Outcomes (1)

  • 1-year mortality

    1-year mortality evaluated by cox model and logistic regression

    up to 12 months

Secondary Outcomes (1)

  • Serum Albumin concentration change

    up to 12 months

Study Arms (2)

Intervention group

EXPERIMENTAL

Participants identified as high-risk for malnutrition-related mortality by prediction model are cluster-randomized into study group. Interventions: In this group, participants will be given common clinical screening for clinical or sub-clinical infection and also oral nutrition supplement (ONS) if albumin is \< 3.8 g/dl. Parameters for outcome measurements are recorded monthly (such as biochemical data) or quarterly (such as Body Composition Monitor (BCM) or Malnutrition Inflammatory Score (MIS). Hospitalization or Mortality events will be recorded when happened.

Dietary Supplement: ONS

Control group

NO INTERVENTION

Participants identified as high-risk for malnutrition-related mortality by prediction model are cluster-randomized into control group. In this group, participants will not be given any intervention, but only outcome measurements are recorded monthly (such as biochemical data) or quarterly (such as Body Composition Monitor (BCM) or Malnutrition Inflammatory Score (MIS). Hospitalization or Mortality events will be recorded when happened.

Interventions

ONSDIETARY_SUPPLEMENT

High-risk patients identified by prediction model in study group are intervened by pre-defined intervention protocol, which include oral nutrition supply, infection prevention, bp control and improving of dialysis therapy options and so on.

Also known as: Clinical Infection Screening, Clinical procedure for malnutrition prevention
Intervention group

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Maintenance Hemodialysis Patients (MHD) patients from multiple centers identified by the risk models as high-risk patients

You may not qualify if:

  • Acute patients
  • Terminal Cancer Patients with life expectancy \< 3 months
  • Age \< 20 year-old
  • Active infection, including Tuberculosis and AIDS
  • Patients received ONS 1 month before enrollment
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

An Hsin Clinic

Taichung, Taiwan

Location

MeSH Terms

Conditions

Protein-Energy MalnutritionMalnutrition

Condition Hierarchy (Ancestors)

Protein DeficiencyDeficiency DiseasesNutrition DisordersNutritional and Metabolic Diseases

Study Officials

  • Huan Sheng Chen, MD

    An Hsin QingShui Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 18, 2018

First Posted

August 22, 2018

Study Start

June 1, 2020

Primary Completion

May 31, 2021

Study Completion

April 26, 2022

Last Updated

August 9, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations